Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astria Therapeutics (ATXS) Notes Payables: 2017

Historic Notes Payables for Astria Therapeutics (ATXS) over the last 1 years, with Dec 2017 value amounting to $2.5 million.

  • Astria Therapeutics' Notes Payables fell 74.65% to $831,000 in Q2 2018 from the same period last year, while for Jun 2018 it was $831,000, marking a year-over-year decrease of 74.65%. This contributed to the annual value of $2.5 million for FY2017, which is N/A change from last year.
  • As of FY2017, Astria Therapeutics' Notes Payables stood at $2.5 million.
  • In the past 5 years, Astria Therapeutics' Notes Payables registered a high of $2.5 million during FY2017, and its lowest value of $2.5 million during FY2017.
  • Its 1-year average for Notes Payables is $2.5 million, with a median of $2.5 million in 2017.